Reversible Decrease of Surface ß₂-Adrenoceptor Number and Response in Lymphocytes of Patients with Pheochromocytoma

References

• Harden T. K. Agonist-induced desensitization of the β-adrenergic receptor-linked adenylate cyclase. Pharmacol Rev. 1983; 35: 5–32
   PubMed Web of Science ®Google Scholar
• Williams L. T., Snyderman R., Lefkowitz R. Identification of β-adrenergic receptors in human lymphocytes by (-)[3H]-alprenolol binding. J Clin Invest. 1976; 149–155
   PubMed Web of Science ®Google Scholar
• Motulsky H. J., Cunningham E. M.S., De Blasi D., Insel P. A. Agonists promote rapid desensitization and redistribution of β-adrenergic receptors on intact human mononuclear leukocytes. Am J Physiol. 1986; 250: E683–E590
   Google Scholar
• Krall J. F., Connelly M., Tuck M. L. Acute regulation of β-adrenergic catecholamine sensitivity in human lymphocytes. J Pharmacol Exp Ther. 1980; 214: 554–560
   PubMed Web of Science ®Google Scholar
• Galant S. P., Duriseti L., Underwood S., Insel P. A. Decreased β-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med. 1978; 299: 933–926
   PubMed Web of Science ®Google Scholar
• De Blasi A., Maisel A. S., Feldman R. D. In vivo regulation of β-adrenergic receptors on human mononuclear leukocytes: assesment of receptor number, location and function after posture change, exercise and isoproterenol infusion. J Clin Endocrinol Metab. 1986; 63: 847–853
   PubMed Web of Science ®Google Scholar
• Snavely M. D., Motulsky H. J., Moustafa E., Mahan L. C., Insel P. A. β-adrenergic receptor subtypes in the rat renal cortex: selective regulation of β1-adrenergic receptors by pheochromocytoma. Circ Res. 1982; 51: 504–513
   PubMed Web of Science ®Google Scholar
• Snavely M. D., Motulsty H. J., O'Connor D. T., Ziegler M. G., Insel P. A. Adrenergic receptors in human and experimental pheochromocytoma. Clin Exp Hypertens A. 1982; 4(4–5)829–848
   PubMed Web of Science ®Google Scholar
• Snavely M. D., Mahan L. D., O'Connor D. T., Insel P. A. Selective down-regulation of adrenergic receptor subtypes in tissues from rats with pheocromocytoma. Endocrinology. 1983; 113: 354–361
   PubMed Web of Science ®Google Scholar
• Tsujimoto G, Manger W. M., Hofmann B. B. Desensitization of β-adrenergic receptors by pheocromocytoma. Endocrinology. 1984; 114: 1272–1278
   PubMed Web of Science ®Google Scholar
• Hoffman B. Adrenergic pharmacology in rats harbouring pheochromocytoma. Hypertens. 1991; 18(suppl III)III-35–III-39
   Google Scholar
• Chobanian A. V., Tifft C. P., Sackel H., Pitruzella A. α and β-adrenergic receptor activity in circulating blood cells of patients of idiopathic orthostatic hypotension and pheocromocytoma. Clin Exp Hypertens (A) 1982; 4: 793–806
   PubMed Web of Science ®Google Scholar
• Ratge D., Wisser H. α and β-adrenergic receptor activity in circulating blood cells of patients with pheochromocytoma: effects of adrenalectomy. Acta Endocrinologica. 1986; 111: 80–88
   PubMedGoogle Scholar
• Valet P., Damase-Mitchel C., Chamontin B., Duramnd D., Chollet F., Montastruc J. L. Platelet α2- and leucocyte β2-adrenoceptors in phaeocromocytoma: effect of tumor removal. Eur J Clin Invest. 1988; 18: 481–485
   PubMed Web of Science ®Google Scholar
• Middeke M. Synchronicity of circadian blood pressure rhythm and sympatho-adrenergic activity. Z. Kardiol. 1992; 81(Suppl 2)55–58
   PubMedGoogle Scholar
• Saffitz J E., Liggett S B. Subcelular distribution of β2-adrenergic receptors delineated with quantitative ultrastructural autoradiography of radioligand binding sites. Circ Res 1992; 70: 1320–1325
   PubMed Web of Science ®Google Scholar
• Staehelin M., Hertel C. 3H-CGP-12177, a β-adrenergic ligand suitable for measuring cell surface receptors. J Recept Res. 1983; 3: 35–43
   PubMed Web of Science ®Google Scholar
• De Blasi A., Lipartitti M., Motulsky H. J., Insel P. A., Fratelli M. J. Agonist-induced redistribution of β-adrenergic receptors on intact human mononuclear leucocytes redistributed receptors are nonfunctional. J Clin Endocrinol Metab. 1985; 61(6)1081–1088
   PubMed Web of Science ®Google Scholar
• Peuler J. D., Johnson G. A. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 1977; 21: 625–636
   PubMed Web of Science ®Google Scholar
• Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 1968; 21(Suppl 97)77–89
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci. 1949; 51: 660–672
   Web of Science ®Google Scholar
• Munson P J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Analytical Biochem. 1980; 107: 220–239
   PubMed Web of Science ®Google Scholar
• Fraser J., Nadeau J., Robertson D., Wood A. J.J. Regulation of human leukocyte β-receptors by endogenous catecholamines. J Clin Invest. 1981; 67: 1777–1784
   PubMed Web of Science ®Google Scholar
• Halawa B. Arterial hypertension. Density of α-adrenergic receptors in blood platelets, β-adrenergic receptors in lymphocytes and serum catecholamine levels. Kardiol Pol. 1991; 35(12)340–344
   PubMedGoogle Scholar
• Ligget S. B., Marker J. C., Shah S. D., Roper C. L., Cryer P. E. Direct relationship between mononuclear leukocyte and lung β-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular α and β adrenergic receptors by the sympathochromaffin system in humans. J Clin Invest. 1988; 82: 48–56
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Connelly-Fittinghoff M., Tuck M. L., Krall J. F. Acute changes in noradrenaline levels do not alter lymphocyte β-adrenergic receptor concentrations in man. Cardiovasc Res. 1983; 17: 184–188
   PubMed Web of Science ®Google Scholar
• Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G. Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967; 214: 597–598
   PubMed Web of Science ®Google Scholar
• Bravo E, Fouad-Tarazi F, Rossi G, Immamura M, Lin W., Madkour M. A., Wicker P, Cressman M D, Saragoca M. A re-evaluation of pheochromocytoma. Hypertension 1990; 15(suppl 1)S128–S131
   Google Scholar
• Fouad-Tarazi F, Imamura M, Bravo E L, Rossi G, Nagi H. K., Lin W, Cressman M, Wicker P. Differences in left ventricular structural and functional changes between pheochromocytoma and essential hypertension. Role of elevated circulating catecholamines. Am J Hypertens 1992; 5: 134–140
   PubMed Web of Science ®Google Scholar